Cost of Thrombolysis Outpaces Reimbursement in Stroke

The cost of tissue plasminogen activator jumped 111% in the last decade, but reimbursement rose by only 8%, a new study shows, prompting calls for stroke doctors to lobby CMS to increase payments.